Details of the Drug

General Information of Drug (ID: DM20G71)

Drug Name

ST-400

Indication

Disease Entry	ICD 11	Status	REF
Beta thalassemia	3A50.2	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03432364) A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT). U.S. National Institutes of Health.